Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa in Anemia of Cancer (Nonmyeloid Malignancies)
NCT00989092Phase 2Terminated
- Sponsor
- Amgen
- Start
- May 2002
- Primary completion
- Jan 2004
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia in neoplastic disease, sponsored by Amgen. Started May 2002; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
anemia in neoplastic disease
Beyond the preview
Go deeper on NCT00989092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989092.